| ACEKX | AMEFX | ACEKX / AMEFX | |
| Total Expense Ratio | 0.48 | 0.37 | 130% |
| Annual Report Gross Expense Ratio | 0.49 | 0.37 | 132% |
| Fund Existence | 16 years | 18 years | - |
| Gain YTD | 8.097 | 8.815 | 92% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 250 | 400,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 12.9B | 150B | 9% |
| Annual Yield % from dividends | 1.83 | 3.55 | 52% |
| Returns for 1 year | 6.66 | 5.18 | 129% |
| Returns for 3 years | 24.21 | 39.42 | 61% |
| Returns for 5 years | 5.70 | 26.11 | 22% |
| Returns for 10 years | 41.53 | 62.25 | 67% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| CDVZX | 21.51 | 0.15 | +0.70% |
| Columbia Intrinsic Value Institutional | |||
| FFOTX | 54.76 | N/A | N/A |
| Fidelity Advisor Technology - Z | |||
| FRBRX | 213.20 | N/A | N/A |
| Franklin Biotechnology Discovery R6 | |||
| BIREX | 16.30 | N/A | N/A |
| BlackRock Real Estate Securities Instl | |||
| EFEAX | 11.88 | N/A | N/A |
| Ashmore Emerging Mkts Frontier Eq A | |||